Install the app
Seer nsclc statistics. This is called staging.
Seer nsclc statistics. 1). Objective Young patients diagnosed with non-small cell lung cancer (NSCLC) present unique clinical, pathological, and genetic features, resulting in a highly heterogeneous patient population. Abstract Background: As the non-small cell lung cancer (NSCLC) adjuvant treatment landscape evolves, an evaluation of treatment patterns and outcomes of patients with early-stage, resected NSCLC eligible for adjuvant treatment in routine clinical practice is needed to better understand the unmet needs in this patient population. This study aims to develop a nomogram model for survival prediction in young patients with metastatic NSCLC at Jul 15, 2024 · In 2024 lung cancer statistics, approximately 235,000 people in the United States will be diagnosed and 125,000 will die from the disease. total out-of-pocket costs and $4. Non-small cell lung cancer (NSCLC) accounts for 80 to 85% of cases. What is more, our results showed that surgery of primary site was associated with longer OS of NSCLC patients with brain metastasis. Methods Surveillance Epidemiology and End Results (SEER) patients with stage IV NSCLC diagnosed from 1991 to 2007 and followed Sep 27, 2024 · Article Open access Published: 27 September 2024 Nomogram predicting overall and cancer specific prognosis for poorly differentiated lung adenocarcinoma after resection based on SEER cohort Apr 3, 2020 · Background Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer death in the world. Anaplastic thyroid cancer (ATC) is the rarest form of thyroid cancer known to humans. Aims: We used the Surveillance, Epidemiology, and End Results (SEER) database to investigate the changes in the incidence, treatment patterns, and outcomes of early-stage non-small cell lung cancer (NSCLC) in octogenarians and older from 1995 to 2015. Get detailed information about newly diagnosed and recurrent NSCLC in this summary for clinicians. Dec 1, 2024 · Non-small cell lung cancer (NSCLC) accounts for 85 % of lung cancer cases. This noninterventional, real-world study enrolled consecutive patients with resected stages IA to IIIB (American Joint Committee on Cancer eighth edition) NSCLC from 14 countries across Asia, Latin America, and the Middle East and Africa. Age at diagnosis of advanced NSCLC is much older, but studies describing the practice patterns for octogenarians with distant May 29, 2024 · e20090Background: Lung cancer is the second most common cancer in terms of incidence and the leading cause of cancer-related deaths. gov/） 是美国国家癌症研究所和人口科学部门于1973年发起的监测流行病学和生存结果的项目。 Jun 23, 2016 · 美国SEER数据库怎么下载使用？某宝有店主提供帮助指导服务，有人购买过吗？ SEER数据库采用的肿瘤分类不是依据TNM分期，而是SEER分期，分为Localized，Regional和Distant，基本约等于大家所说的癌症早期、中期和晚期。 各癌症类型5年生存率汇总及排名 解读补充： Stage III non-small cell lung cancer (NSCLC) includes a highly heterogeneous group of patients with differences in the extent and localization of disease. However, little is known about the impact of delay in time to diagnosis. Plus variable definitions, documentation for reporting and using datasets, statistical software (SEER*Stat), and observational research resources. Methods Data of DPLC patients from the database from 1992 to 2020 were Jan 1, 2023 · We review research regarding the epidemiology, risk factors, genetic susceptibility, molecular pathology, and early detection of SCLC, a deadly tumor that accounts for 14% of lung cancers. 2019;94: Dec 22, 2023 · This retrospective study identified patients in the SEER–Medicare database (2007-2019) with newly diagnosed stage II, IIIA, and IIIB (N2) NSCLC (AJCC 8th edition) treated with neoadjuvant chemo/chemoradiotherapy and resection (index date: neoadjuvant therapy initiation). SCC, sometimes called epidermoid carcinoma, is more prevalent in men and arises in the lining of the large air passageways, or bronchi. We collected data from the Surveillance, Epidemiology, and End Results (SEER) database of the National Cancer Institute in the United States. Feb 5, 2025 · Methods: A retrospective, population-based study was conducted utilizing the Surveillance, Epidemiology, and End Results (SEER) program to identify patients with SCLC from 2000 to 2020. Joinpoint regression models were used to estimate the rate changes in lung After someone is diagnosed with non-small cell lung cancer (NSCLC), doctors will try to figure out if it has spread, and if so, how far. The C-index Feb 14, 2025 · Survival prognostic nomogram for young metastatic non-small cell lung cancer: a study of the US SEER database and a Chinese cohort Mortality trends are based on death certificate data from 1975 through 2022 reported to the National Vital Statistics System. The SEER program is the only source for historic population‐based incidence data (1975–2020) and currently contains data from the eight oldest SEER areas (Con-necticut, Hawaii, Iowa, New Mexico, Utah, and the metropolitan areas of Atlanta, San Francisco‐Oakland, and Seattle‐Puget Sound), representing approximately 8% of the US Aug 1, 2024 · The results of this large-scale retrospective study indicate that both surgery and radiotherapy significantly enhance survival outcomes in patients aged ≥70 or ≥80 years with early-stage NSCLC. The study’s key findings underscore the survival advantage associated Methods Outcomes of patients with stage IA non-small cell lung cancer (NSCLC) ≤3 cm who underwent lobectomy without induction therapy in the Surveillance, Epidemiology, and End Results-18 (SEER-18; January 2004 to December 2016) database were evaluated using multivariable Cox proportional hazards modeling and propensity score-matched analysis. Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes using incidence data collected by central cancer Apr 1, 2015 · Tumor size is a known prognostic factor for early stage non–small-cell lung cancer (NSCLC), but its significance in node-positive and locally invasive NSCLC has not been extensively characterized. Trends in cancer incidence, incidence-based mortality rates, 1-year relative survival rates and 1-year observed survival were evaluated utilizing the SEER database. Information about SEER*Stat database for November 2022 submssion: dictionary of variables, rate and prevalence sessions, survival and left-truncated life table sessions, case listing and frequency sessions, delay adjustment databases for incidence, MP-SIR/SMR sessions. Duma N, et al. With the advances in thyroid ultrasounds and screening protocols, the incidence of ATC increases, which correlates with the increase in papillary thyroid cancer (PTC) that is believed to be the precursor of most Anaplastic thyroid cancer (ATC) is the rarest form of thyroid cancer known to humans. 同为临床狗，曾自己摸索过多个公开临床数据库，也利用它们发过一些sci文章，现来推荐一个门槛较低的公开免费临床数据库，望对那部分没有课题、没有数据的人能有一点帮助，但是需适可而止，毕竟有些大佬很diss这种行为。 SEER、TARGET、TCGA等都是著名的肿瘤数据库，但是对于非肿瘤专业的人 中央空调系统的能效比（EER）或季节能效比（SEER）是衡量空调系统效率的关键指标。其中，EER主要应用于定频空调，而SEER则针对变频空调进行评估。以下是具体的测量和维护方法： 测量 了解定义：EER是指在额定工况下，空调器制冷运行时的制冷量与有效输入功率之比。SEER则是在正常供冷期间 SEER数据库（网址：seer. gov/） 是美国国家癌症研究所和人口科学部门于1973年发起的监测流行病学和生存结果的项目。 Jun 23, 2016 · 美国SEER数据库怎么下载使用？某宝有店主提供帮助指导服务，有人购买过吗？ SEER数据库采用的肿瘤分类不是依据TNM分期，而是SEER分期，分为Localized，Regional和Distant，基本约等于大家所说的癌症早期、中期和晚期。 各癌症类型5年生存率汇总及排名 解读补充： Apr 9, 2025 · SEER的价值在于其数十年积累的癌症流行病学数据——覆盖美国34. Apr 9, 2025 · SEER的价值在于其数十年积累的癌症流行病学数据——覆盖美国34. Cancer is the second leading cause of death after heart disease in both men and women nationally but is the lead-ing cause of death in many states90 and in people who are Hispanic, Asian American,91,92 or Alaska Native. In this study, we retrospectively extracted 70006 eligible NSCLC patients from the Surveillance, Epidemiology, and End Results (SEER) database in the period from 2004 to 2012 Dec 26, 2023 · A nomogram model to predict death rate among non‐small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database. With the new data comes the release of many new statistics and updated versions of software throughout the Surveillance Research Program. 8 million deaths in 2022. The report includes long-term trends since 2001 and short-term trends with the most recent five years of data, which covers 2017 – 2021 for incidence and 2018 – 2022 for mortality. 3 The two primary types of lung cancer are non-small cell lung cancer (NSCLC), which accounts for 81% of cases, and small cell lung cancer (SCLC), which accounts for 14% of cases. Learn more about NSCLC in this expert-reviewed summary. 5 million new cases and 1. Accessed June 16, 2021. Patients who received surgery between 2010 and 2015 for N2 NSCLC were included. Especially in the United States, among patients diagnosed with non–small cell lung cancer (NSCLC) from 2011 to 2017, the 5-year relative survival rate was 26% in all stages and only 8% in cases with distant metastases. This study examined overall survival (OS) and cancer-specific survival in patients with NSCLC in the Jan 17, 2024 · All 22 SEER registries (additionally Massachusetts and Illinois), covering 48% of the United States, were the source for the probability of developing cancer. It helps determine how best to treat it. Laser therapy, photodynamic therapy, cryosurgery, and electrocautery may be used. A nomogram was developed by integrating all Cancer Facts & Figures 2023 is an educational companion for Cancer Statistics 2023, a scientific paper published in the American Cancer Society journal, CA: A Cancer Journal for Clinicians. Learn how it differs from small cell, its causes, symptoms, types, treatment and survival rate. we aim to develop a nomogram in order to predict the survival of patients with metastatic lung adenocarcinoma. 7。 我们知道一个房间在夏季维持室内舒适温度（假设25℃恒温）是要不停地 现在 SEER数据库 必须要era common account才能拿到详细一点的数据啊。我也想知道怎么注册 SEER数据库采用的肿瘤分类不是依据TNM分期，而是SEER分期，分为Localized，Regional和Distant，基本约等于大家所说的癌症早期、中期和晚期。 各癌症类型5年生存率汇总及排名 解读补充： Jun 23, 2016 · 美国SEER数据库怎么下载使用？某宝有店主提供帮助指导服务，有人购买过吗？ Apr 9, 2025 · SEER的价值在于其数十年积累的癌症流行病学数据——覆盖美国34. Jun 27, 2016 · Article Open access Published: 27 June 2016 Time-to-Progression of NSCLC from Early to Advanced Stages: An Analysis of data from SEER Registry and a Single Institute Ping Yuan, Jin Lin Cao, Azmat Dec 20, 2023 · Lung cancer is the second most common cancer. See Sources of Statistics on page 41 for more information on data sources and methods. gov. 2. Mar 31, 2025 · The current SEER-Medicare linkage is updated biennially. See data for incidence, mortality, survival, risk and more. Neoadjuvant treatment regimens were described. The correlation between OS and rwEFS was Apr 5, 2020 · Background To evaluate the value of new therapies for non-small cell lung cancer (NSCLC), it is necessary to understand overall survival (OS) rates associated with previous standard therapies and how these rates have evolved over time. This is called staging. Jun 27, 2025 · The life expectancy of someone with non-small cell lung cancer (NSCLC) depends on the stage of cancer and treatment. We collected data from the Surveillance, Epidemiology, and End Results (SEER) Feb 23, 2023 · In this study, we analyzed the homogeneous and heterogeneous risk/prognostic factors of brain metastasis in lung cancer patients. The strong correlation between rwEFS and OS suggests that EFS may serve as a good predictor for OS and be a clinically relevant trial endpoint. Objectives Large population-based studies on the incidence and outcome of non-small cell lung cancer (NSCLC) are lacking in mainland China. Doctors also use a cancer’s stage when talking about survival statistics. The data currently include all Medicare eligible persons appearing in the SEER data who were diagnosed with cancer through 2021, and their Medicare claims through 2022. Adenocarcinoma, squamous cell carcinoma, and large- Abstract Purpose This study used the Surveillance, Epidemiology, and End Results (SEER) data to investigate the changes in incidence, treatment, and survival of lung cancer from 1973 to 2015. gov/） 是美国国家癌症研究所和人口科学部门于1973年发起的监测流行病学和生存结果的项目。 中央空调系统的能效比（EER）或季节能效比（SEER）是衡量空调系统效率的关键指标。其中，EER主要应用于定频空调，而SEER则针对变频空调进行评估。以下是具体的测量和维护方法： 测量 了解定义：EER是指在额定工况下，空调器制冷运行时的制冷量与有效输入功率之比。SEER则是在正常供冷期间 冷暖型和单冷型空调不同能效等级的能效比 冷暖两用空调用全年能源消耗效率（APF)来表示能效等级。 而单冷空调用制冷季节能源消耗效率（SEER）来表示能效等级。 我们以单冷1. We queried the Surveillance, Epidemiology, and End Results database to evaluate the prognostic value of tumor size for early stage and node-positive and locally invasive NSCLC. CA Cancer Clin. Types of Lung Cancer Non-Small Cell Lung Cancer (NSCLC) Most lung cancers are classified as non- small cell lung cancer (NSCLC). 5就是一级能效，现在要5. D. Patients and methods The clinical and epidemiological data of patients with lung cancer were obtained from the SEER database. 20 The most common subtypes of NSCLC are squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. This study aimed to investigate the NSCLC incidence, demographic features and survival as well as factors affecting survival of patients with NSCLC in Shanghai. Apr 9, 2025 · This study examined patients with Non-Small Cell Lung Cancer (NSCLC) to understand the strengths and limitations of a novel integrated research environment called Generating Evidence Excellence (GEx). Little is known about the time-trends in incidence of NSCLC in the young, their Jul 10, 2024 · Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a Surveillance, Epidemiology, and End Results (SEER) analysis Five year survival update from KEYNOTE-010: pembrolizumab versus docetaxel for previously treated, programmed death-ligand 1–positive advanced NSCLC Jul 12, 2023 · Outcomes by ethnicity, based on a study of 96,480 NSCLC patients identified using the Surveillance, Epidemiology, and End Results (SEER) database, suggested that Native Americans and Alaskan natives with stage I disease had lower 5-year CRS rates compared with other groups, although this difference diminished with time [27]. The survival benefits of surgery were particularly notable. Note 2: If the case is accessioned (added to your database) based on a single histology described by ambiguous terminology and no other histology information is available/documented, then code that histology. These findings highlight the need … Apr 1, 2023 · We retrieved data from SEER database. Apr 13, 2023 · Survival Rates by SEER Stage The American Cancer Society breaks down SEER lung cancer survival rates by the type (NSCLC or SCLC) and stage (localized, regional, or distant). 2 days ago · The SEER-Medicare database (2007-2020) was used to identify patients with stage I-IIB (N0) NSCLC receiving primary SBRT. Simply select your manager software from the list below and click Download. 序列号 (Sequence Number) * 用于识别同一患者的多次肿瘤记录。 * 筛选逻辑：同一患者的序列号大于1，表明存在第二原发肿瘤。 2. For example, NSCLC 2-year relative survival increased from 34% for persons diagnosed during 2009 through 2010 to 42% during 2015 through 2016, including absolute increases of 5% to 6% for every stage of diagnosis; survival for small cell lung cancer remained at 14% to 15%. These annual reports provide: Estimated numbers of new cancer cases and deaths in 2024 by cancer site and US state Current cancer incidence, mortality, and survival statistics Information on cancer symptoms May 27, 2025 · Background Recent therapeutic advancements for non-metastatic non-small cell lung cancer (NSCLC) have increased the need for real-world baselines against which future changes in patient management and clinical outcomes can be compared. Aug 3, 2023 · We acquired lung cancer patients diagnosed during 2001–2019 from the National Program of Cancer Registries (NPCR) and Surveillance, Epidemiology and End Results (SEER) Program SEER*Stat Database The Annual Report to the Nation on the Status of Cancer published statistics on new cancer cases, deaths, and trends in the United States. By Cox regression, we constructed prognostic nomogram of resected NSCLC-NET. National Cancer Institute. from Memorial Sloan Kettering Cancer Center found previously unknown associations between four protein isoforms and non-small cell lung cancer (NSCLC) progression, constituting potential novel, disease-relevant biomarkers, or therapeutic targets. 2 NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer. 0以上才是了，很多一级能效空调按新国标算就是二级了。 另外就是 定频空调 的能效比计算方式由 EER 变为APF或者 SEER。 附上对比表格，来源中国制冷与空调网，侵删。 SEER数据库（网址：seer. Feb 4, 2022 · Time from diagnosis to treatment has been associated with worse survival outcomes in non–small-cell lung cancer (NSCLC). 85% of all lung cancer cases are categorised as non-small cell lung cancer (NSCLC). Key findings • Our comprehensive analysis of 37,323 non-small cell lung cancer (NSCLC) patients from the Surveillance, Epidemiology, and End Results (SEER) database elucidates the pivotal role of lymph node dissection (LND) in enhancing cancer-specific survival, particularly among early-stage patients. Jul 10, 2024 · Abstract Background: In 2015, the US Food and Drug Administration approved nivolumab as the first immunotherapy for patients with advanced non-small cell lung cancer (NSCLC). We selected 922,317 lung cancer patients diagnosed from 2000 to 2017 for survival analysis to provide updated data for Background Lung adenocarcinoma (LUAD) is the most common type of Non-small-cell lung cancer (NSCLC). It was developed with the idea to provide a geographic profile of cancer burden in the United States and reveal geographic patterns of cancer incidence, mortality, risk factors for cancer, and cancer Cancer Facts & Figures 2024 is an educational companion for Cancer Statistics 2024, a scientific paper published in the American Cancer Society journal, CA: A Cancer Journal for Clinicians. Aug 13, 2020 · BACKGROUND Lung cancer is made up of distinct subtypes, including non–small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Methods Patients diagnosed with NSCLC, CSCLC, and pure SCLC between 2004 and 2015 were identified from the Surveillance Epidemiology and End Results (SEER) database. and for SEER are compared to assess the representation of SEER to the U. Abstract Marital status has been demonstrated to be related to the survival of patients in various cancer types, but the relationship in the large population of non-small cell lung cancer (NSCLC) has rarely been studied. The data supporting treatment approaches Read about cancer statistics, surveillance, data, and resources regularly updated or supported by the Surveillance Research Program. Find out more about life expectancy. Jun 25, 2024 · A study investigating how many patients with early-stage non-small cell lung cancer (NSCLC) had mutations in a protein called EGFR and which treatments they received in routine clinical practice: The treatment recommended by medical experts for stage IA–IIIA non-small cell lung cancer (NSCLC) is surgical removal of the growth (tumor). NSCLC indicates non–small cell lung cancer; SCLC, small cell lung cancer; SEER, Surveillance, Epidemiology, and End Results program. We collected data from the Surveillance, Epidemiology, and End Results (SEER) database of Nov 1, 2024 · Improved survival of patients with stage III small-cell lung cancer with primary resection: A SEER-based analysis Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. We aimed to evaluate the impact of time from radiographic suspicion to histologic diagnosis on survival outcomes using the US SEER-Medicare population database. 7 Historical survival data (1975–1977 Aug 28, 2021 · Treatment of lung cancer depends on the stage of the tumor and the histological type. 6%人口、超千万病例的临床信息，是探索癌症地域分布、治疗差异的核心依据。 SEER数据库收集和存储了全美范围内的 癌症发病率、生存率和治疗数据，以支持癌症研究和流行病学调查。 SEER数据库包含了来自各个州的注册癌症患者的信息，其中包括患者的人口学特征（如年龄、性别、种族）、癌症类型、诊断时间、治疗方法和生存状况等。 按照seer database检索获取的文章数量 很多人都在说现在学习seer晚了，现在seer文章很难发了，诸如此类的话。但是事实上seer数据库挖掘的文章正在逐年上升，并且发了不少高质量的文章。对此我觉得有以下原因： 数据库是客观存在于此，但是临床问题是不断变化更新的。在我们临床实践工作总是会 Jul 3, 2020 · 除了级别多了，不同能效的能效比也变了。 以变频空调为例，以前 APF 超过4. Discover survival rates for non-small cell lung cancer, factors that affect prognosis, and what to expect during treatment. The primary end point was prevalence of EGFR mutations and secondary end points included prevalence of EGFR mutation subtypes and treatment patterns. Jun 20, 2025 · Survival rates for stage 3 lung cancer by age can vary along with other factors. The latest lung cancer statistics for the UK for Health Professionals. Dec 20, 2024 · Did you know that lung cancer’s five-year survival rate changes based on the stage when found? Early-stage lung cancer has a survival rate of about 61%. However, population-based survival benefit studies after the introduction of immunotherapy in lung cancer are lacking. Design A retrospective population-based study. May 16, 2025 · Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. The aim of the study was to develop a validate … Jul 17, 2020 · This study aimed to establish a novel nomogram prognostic model to predict death probability for non-small cell lung cancer (NSCLC) patients who received surgery. Many aspects of stage III disease are controversial. Apr 11, 2025 · Objective This study aimed to develop a concise and valid clinical prediction model to assess the survival prognostic risk of cancer-specific death in patients with dual primary lung cancer (DPLC). SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS). 3. Jan 9, 2023 · Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases, which has an improving overall survival rate due to better therapy (2). Aug 1, 2019 · The 60-month overall survival rate for non–small cell lung cancer (NSCLC) remains poor, from 68% in patients with stage IB disease to 0% to 10% in patients with stage IVA-IVB disease. Mayo Clin Proc. May 29, 2025 · Steps to obtain data The data in the U. The Global Cancer Observatory (GCO) is an interactive web-based platform presenting global cancer statistics to inform cancer control and research. Researchers studied records from US patients diagnosed with NSCLC between 2015 and 2019 from two different data sources within GEx. Nov 20, 2019 · This cohort study compares long-term overall survival of patients with early-stage non–small cell lung cancer treated with stereotactic body radiotherapy vs surgery including various degrees of lymph node examination. Its epidemiology depends not only on tobacco exposition but also air quality. Cancer Statistics public use database come from CDC's National Program of Cancer Registries (NPCR) and the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program. Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer death worldwide, with about 2. Methods We retrospectively analyzed data from patients enrolled in the Surveillance, Epidemiology, and End Results (SEER) cancer registry. Sep 20, 2021 · Non-small cell lung cancer (NSCLC) is a subtype of the most frequently diagnosed cancer in the world. Although the median age at diagnosis of non-small cell lung cancer (NSCLC) is 70 years, a subset of patients with NSCLC present at a younger age (<40 years). seer. Regrettably, LUAD continues to exhibit a notably unfavorable overall prognosis. The North American Association of Central Cancer Registries (NAACCR) compiles and reports incidence data from 1995 forward for registries that participate in the SEER program and/or the NPCR. May 26, 2019 · Determinants of early discontinuation of first-line chemotherapy, and associated outcomes among elderly with advanced non-small cell lung cancer. These lung cancer facts and statistics can tell you more about this type of cancer and your risks. Abstract Background: Immune checkpoint inhibitors (ICIs) have been included in various neoadjuvant therapy (NAT) regimens for non-small cell lung cancer (NSCLC). We first summarize the changing incidences of SCLC globally and in the United States among males and females. , tobacco smoking) and suspected nonsmoking Non–small cell lung cancer accounts for 85% of all lung cancer cases in the United States. Methods Data on patient characteristics, initial treatment, and overall survival (OS) were derived from adult patients diagnosed with stage I-IIIC NSCLC (2010 The EARLY-EGFR study provides an overview of EGFR mutations and subtype prevalence in patients with early stage NSCLC. Learn about survival rates here. We then review the established risk factor (i. Mar 29, 2023 · Scientists from Seer in collaboration with Luis Diaz, M. Although overall mortality from lung cancer has been declining in the United States, little is known about mortality trends About State Cancer Profiles State Cancer Profiles is an interactive map engine produced in collaboration between the National Cancer Institute and Centers for Disease Control and Prevention. Keywords: Lung adenocarcinoma, metastasis, non‐small cell lung cancer, overall survival, prognostic factor In this study we identified male sex, age = 65 years, lack of family support and liver and brain metastases as poor prognostic factors for overall survival (OS) in patients with stage IV lung ADC. NSCLC is further categorized as adenocarcinoma, which is slightly more common in women, followed by Preliminary estimates predict the rates and trends that will become available once the data are released in April. Background: Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer death in the world. Patients were categorized into recurrence and nonrecurrence cohorts based on disease recurrence status post-SBRT. The stage of a cancer describes how much and where the cancer is in the body. 7 Historical survival data (1975–1977 and The statistics presented in these stat facts are based on the most recent data available, most of which can be found in SEER*Explorer. We sought to evaluate racial and ethnic trends and disparities in NSCLC incidence and survival by stage at diagnosis during a time period in which new early detection screening and treatment options have become available. Methods This study used data from the Oncology Outcomes Recurrence after SBRT in unresected, early-stage NSCLC was associated with worse survival and substantial economic burden. The nomogram was evaluated by ROC, calibration plot and decision curve analysis (DCA) and compared with 8th TNM staging system. However, due to the relatively short period for the use of ICIs in NAT, patients' clinical outcomes with different regimens are uncertain. 0以上才是了，很多一级能效空调按新国标算就是二级了。 另外就是 定频空调 的能效比计算方式由 EER 变为APF或者 SEER。 附上对比表格，来源中国制冷与空调网，侵删。 在SEER数据库中筛选第二原发肿瘤，需要结合多个字段进行综合判断。 以下列举了一些关键字段及其筛选逻辑，供您参考： 1. cancer. Jun 25, 2024 · In 2024, approximately 235,000 people in the United States will be diagnosed with lung cancer, and 125,000 will die from the disease. Distant metastasis of lung adenocarcinoma reduces the survival rate. Life expectancy is also affected by whether tumors can be treated with surgery. . 2021;71:209-249. rwEFS (time from index to first recurrence or death, whichever occurred May 2, 2017 · Classified as a neuroendocrine tumor despite its differences with non-small cell lung cancer (NSCLC), SCLC is distinctly different from extrapulmonary small cell carcinoma in disease progression Jan 16, 2025 · The SEER program is the only source for historic population-based incidence data from the eight oldest SEER areas (Connecticut, Hawaii, Iowa, New Mexico, Utah, and the metropolitan areas of Atlanta, San Francisco-Oakland, and Seattle-Puget Sound), representing approximately 8% of the US population. www. Mar 4, 2024 · Lung cancer is the most commonly occurring cancer globally, and the leading cause of cancer death worldwide. Randomized phase I/II trial of pembrolizumab with and without radiotherapy for metastatic non-small cell lung cancer. e. Apr 16, 2025 · Options for accessing datasets for incidence, mortality, county populations, standard populations, expected survival, and SEER-linked and specialized data. Apr 26, 2021 · Methods Data from the open Surveillance, Epidemiology, and End Results (SEER) database from the National Cancer Institute in the United States were used to construct a nomogram. Independent prognostic factors for survival identified through Cox regression analysis were used to create the nomogram. Highlight box. OS, all-cause and NSCLC-related HRU, and health care costs were compared between patients with and without recurrence. Non-small cell lung cancer (NSCLC) accounts for 85 % of lung cancer cases. Adults with This study included almost all patients with stage IIIB non‐small cell lung cancer from the Surveillance, Epidemiology and End Results (SEER) database to analyze the clinical characteristics and treatment options. 0，5级是3. Survival analyses were performed by using the Kaplan Meier curves and Cox proportional hazards regression. The highest incidence and mortality rates in both sexes are found in most parts of Europe, North America, and Australia/New Zealand and the lowest in sub-Saharan Africa (Map 14. In recent years, the histological confirmation of lung non-small-cell lung cancer has become crucial since the availability of selective target therapeutic approaches. Our goal is to evaluate the effects of including and excluding race/ethnicity as a predictive covariate in model performance and fairness Apr 16, 2025 · SEER Data are now available the for the years 1975-2022. It helps patients understand their prognosis and choose treatments. But, for advanced stages, it falls dramatically to 7%. The study highlights the limited adherence to treatment guidelines suggesting an unmet need for improved adjuvant therapy. Apr 29, 2024 · There are various therapeutic methods for stage IA (T1N0M0) non-small cell lung cancer (NSCLC), and we did a retrospective descriptive study using data from the US SEER database. May 30, 2025 · Treatment and survival Lung cancer is classified as small cell lung cancer (13% of cases) or nonsmall cell lung cancer (NSCLC; 83% of cases), with about 4% of cases lacking information on histology. 3 Some environmental and lifestyle factors have been associated with the subsequent development of lung cancer, of which cigarette smoking is the most important. However, knowledge of long-term survivor frequency and characteristics prior to modern therapies is lacking. May 1, 2024 · Background Standard treatment for early-stage or locoregionally advanced non-small cell lung cancer (NSCLC) includes surgical resection. A Chinese cohort was used for external validation. For this study, we considered two primary outcomes: survival of two-years after diagnosis and surgery treatment recommendation. The current TNM staging system is insufficient for accurately predicting their prognosis. They are analyzed using SEER*Stat software, which is distributed by the SEER Program. Aims We used the Surveillance, Epidemiology, and End Results (SEER) database to investigate the changes in the incidence, treatment patterns, and outcomes of early-stage non-small cell lung cancer (NSCLC) in octogenarians and older from 1995 to 2015. Among the other thyroid neoplasms, ATC is the deadliest, with unified mortality of almost 100%. 6%人口、超千万病例的临床信息，是探索癌症地域分布、治疗差异的核心依据。 按照seer database检索获取的文章数量 很多人都在说现在学习seer晚了，现在seer文章很难发了，诸如此类的话。但是事实上seer数据库挖掘的文章正在逐年上升，并且发了不少高质量的文章。对此我觉得有以下原因： 数据库是客观存在于此，但是临床问题是不断变化更新的。在我们临床实践工作总是会 SEER数据库收集和存储了全美范围内的 癌症发病率、生存率和治疗数据，以支持癌症研究和流行病学调查。 SEER数据库包含了来自各个州的注册癌症患者的信息，其中包括患者的人口学特征（如年龄、性别、种族）、癌症类型、诊断时间、治疗方法和生存状况等。 Jul 3, 2020 · 除了级别多了，不同能效的能效比也变了。 以变频空调为例，以前 APF 超过4. Recurrence after surgery is commonly reported, but a summary estimate for postsurgical recurrence-free survival (RFS) in patients with NSCLC is lacking. This study's primary aim was to develop and validate prognostic tools capable of predicting the likelihood of cancer-specific survival (CSS) in patients with LUAD. Dec 17, 2021 · This cohort study investigates the association of stage shift with population mortality among patients diagnosed with non–small cell lung cancer between 2006 and 2016. After the initial diagnosis, accurate staging of non–small cell lung cancer using computed tomography or positron emission tomography is crucial for determining appropriate therapy. Abstract Background New, effective treatments have resulted in long-term survival for small subgroups of metastatic non-small cell lung cancer (NSCLC) patients. View sources of prevalence statistics, types of estimates, and limitations for using cancer registry data to estimate prevalence. Data source Surveillance, epidemiology, and end results (SEER) database. population and are often used to provide national estimates of cancer incidence and survival. Another common type of NSCLC is adenocarcinoma, which occurs at the outer Jun 12, 2025 · Lung and bronchus cancer kills 350 people per day. This article will explain lung cancer staging and what life Note 1: If the case does not meet the criteria in the first two bullets, code non-small cell lung cancer (NSCLC) 8046. Knowing about Lung Cancer Stages Life Expectancy is vital. Jan 27, 2024 · Survival rates are adjusted for normal life expectancy and are based on cases diagnosed in the SEER 8 areas for 1975–2000 and in the SEER 17 areas for 2001–2018; all cases were followed through 2019. In some cases, different year spans may be used. Nov 4, 2024 · Methods: A Cox survival model, and a LOGIT model as well as three other machine learning models for predicting surgery recommendation were trained using SEER data from NSCLC patients diagnosed from 2000-2018. Lung cancer is made up of distinct subtypes, including non–small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Learn more about prevalence and statistics here. 5匹空调为例：1级的SEER是5. Setting Baseline information was collected from This study aimed to establish a novel nomogram prognostic model to predict death probability for non-small cell lung cancer (NSCLC) patients who received surgery. All CSCLC patients were randomly split 7:3 into training and validation sets. Methods Using the SEER database Results Non-Small Cell Lung Cancer NSCLC: IBM, Incidence, and Survival Trends, SEER-18 NSCLC: IBM, Incidence, and Survival Trends, SEER-18 Aug 14, 2018 · 肺癌发病率和死亡率均位居所有恶性肿瘤的第一，严重影响人类健康。非小细胞肺癌（non-small cell lung cancer, NSCLC）中常见病理类型为腺癌和鳞癌，临床研究和关注较多，而肺腺鳞癌是一种较为罕见的肺癌病理类型，其临床特征及预后相关因素尚未完全明确。本研究即对肺腺鳞癌的临床特征及预后进行 Jun 29, 2020 · SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS). 7。 我们知道一个房间在夏季维持室内舒适温度（假设25℃恒温）是要不停地 现在 SEER数据库 必须要era common account才能拿到详细一点的数据啊。我也想知道怎么注册 SEER数据库采用的肿瘤分类不是依据TNM分期，而是SEER分期，分为Localized，Regional和Distant，基本约等于大家所说的癌症早期、中期和晚期。 各癌症类型5年生存率汇总及排名 解读补充： Jun 23, 2016 · 美国SEER数据库怎么下载使用？某宝有店主提供帮助指导服务，有人购买过吗？ NSCLC accounts for 85% of lung cancer cases 3 *Patients diagnosed with regional or distant stage at diagnosis. Dec 10, 2021 · Background On April 15, 2021, the Surveillance, Epidemiology, and End Results (SEER) database released the latest lung cancer follow-up data. Although overall mortality from lung cancer has been On April 15, 2021, the Surveillance, Epidemiology, and End Results (SEER) database released the latest lung cancer follow-up data. fi vances in screening, improvements in targeted treatment for NSCLC, and expanded insurance coverage of these services. Describes how to access the SEER Data, including the research data agreements and authorization steps. Non-small cell lung cancer is the most common form. Sep 9, 2019 · Between 80 and 85% of patients with lung cancer have non-small-cell lung cancer (NSCLC) [1], which is characterized histologically as squamous cell carcinoma or nonsquamous cell carcinoma (adenocarcinoma and large-cell carcinoma) [2, 3]. If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Comparison of treatment patterns, health care utilization, and direct costs in elderly patients with distant-stage small cell lung cancer (SCLC) versus non-small cell lung cancer (NSCLC) using the SEER-Medicare database. Among NSCLC subtypes, lung adenocarcinoma (LUAD) stands as the most prevalent. While the global trends in NSCLC incidence have started to decline, we can observe region-dependent differences related … Dec 3, 2020 · NSCLC indicates nonsmall cell lung cancer; SCLC, small cell lung cancer. May 28, 2025 · Subtype-specific trends in lung cancer incidence and survival: A SEER analysis (2004–2021). About half of these are squamous cell carcinomas (SCC). The SEER program is the only source for historic population‐based incidence data from the eight oldest SEER areas (Connecticut, Hawaii, Iowa, New Mexico, Utah, and the metropolitan areas of Atlanta, San Francisco‐Oakland, and Seattle‐Puget Sound), representing approximately 8% of the US population. The SEER database, maintained by the National Cancer Institute (NCI), tracks 5-year relative survival rates for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) in the United States, based on how far cancer has spread throughout the body. The incidence and prognostic factors were compared between SCLC and NSCLC-NET. Abstract Objective: Data from the 11 Surveillance, Epidemiology, and End Results tumor registries cover 14% of the U. Methods: Using the SEER Apr 9, 2025 · SEER的价值在于其数十年积累的癌症流行病学数据——覆盖美国34. Jul 17, 2020 · This study aimed to establish a novel nomogram prognostic model to predict death probability for non-small cell lung cancer (NSCLC) patients who received surgery. S. 8，3级是5. SRP provides national leadership in the science of cancer surveillance as well as analytical tools and methodological expertise in collecting, analyzing, interpreting, and disseminating reliable population-based statistics. 9 billion in patient time costs (travel to/from treatment and waiting for and receiving care). Apr 20, 2020 · Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis Apr 15, 2024 · Despite decades of declining mortality rates, lung cancer remains the leading cause of cancer death in the United States. Design Prospective observational cohort study. These annual reports provide: Estimated numbers of new cancer cases and deaths in 2023 by cancer site and US state Current cancer incidence, mortality, and survival statistics Information on cancer symptoms Apr 11, 2024 · Non-small cell lung carcinoma is a type of lung cancer that can lead to health complications. This article examines lung cancer incidence, stage at diagnosis, survival, and mortality using population-based data from the National Cancer Institute, the Centers for Disease C … Jan 16, 2025 · Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries (through 2021) and mortality data collecte … What Are the Different Types of Lung Cancer? Lung cancer encompasses a variety of biologically distinct tumors. However, bone metastasis (BM) is a negative prognostic factor in NSCLC patients. Cancer mortality data for the U. Sung H, et al. We selected 922,317 lung cancer patients diagnosed from 2000 to 2017 for survival analysis to provide updated data for lung cancer researchers. Overall rates are twice as high in men than women. Clinical and economic impact of recurrence in unresected non–small cell lung cancer treated with primary stereotactic body radiotherapy: A real-world study using SEER-Medicare data Non-small cell lung cancer (NSCLC) is the most common cancer and the leading cause of cancer-related deaths worldwide. The Annual Report also provides rates and trends for the most common Nov 4, 2024 · This retrospective, population-based study used the SEER database and analyzed NSCLC cases diagnosed between 2000 and 2018 [20]. With the advances in thyroid ultrasounds and screening protocols, the incidence of ATC increases, which correlates with the increase in papillary thyroid cancer (PTC) that is believed to be the precursor of most Mar 10, 2022 · Background As part of the multi-country I-O Optimise research initiative, this population-based study evaluated real-world treatment patterns and overall survival (OS) in patients treated for advanced non-small cell lung cancer (NSCLC) before and after public reimbursement of immuno-oncology (I-O) therapies in Alberta province, Canada. It is also the leading cause of cancer-related death worldwide. zo4xo jml vj2 gostrtfw sklf n5wlt 9dme7b 2zddj 6lmfy vvj